10x Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Outlook for 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to 10x Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Outlook for 2022

10x Genomics (TXG) Misses Q4 EPS by 7c

February 16, 2022 4:39 PM EST

10x Genomics (NASDAQ: TXG) reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $143.5 million versus the consensus estimate of $148.53 million.

GUIDANCE:

10x Genomics sees FY2022 revenue of $600-630 million, versus the... More